Bio Law Blog

NOVEMBER 22, 2021

2131 (2016) and Thryv, Inc. In August 2021, two pharmaceutical companies, Daiichi Sankyo and AstraZeneca, filed a complaint in the Eastern District of Virginia challenging the PTAB’s use of the Fintiv factors in denying PGR. Andrei Iancu , No. 20-cv-6128-EJD (N.D. Lee , 136 S. Click-to-Call Technologies, LP , 140 S.

Litigation 52

Litigation Technology Patent Infringement Patent 52

Patently-O

NOVEMBER 29, 2023

The Federal Circuit rejected this argument based on dicta in Thryv, Inc. Petitioners contend that the Federal Circuit misapplied Thryv and that the plain language of § 315(c) precludes joinder of time-barred parties. Reduxio Systems, Inc., See Amgen, Inc. Click-To-Call Techs., Fortinet, No. Sanofi, 142 S.

Patent Law 73

Patent Law Law Patent Art 73

Fish & Richardson Trademark & Copyright Thoughts

JANUARY 4, 2021

In Arthrex Inc. Smith & Nephew Inc.,[1] Nike Inc.,[6] Samsung Electronics America Inc.,[8] In contrast, in Power Integrations Inc. Last term, the Supreme Court decided Thryv Inc. Efforts to appeal or seek mandamus review of such rulings have all failed, e.g., Cisco Systems Inc.

Art 40

Art Litigation Invention Technology 40

Fish & Richardson Trademark & Copyright Thoughts

FEBRUARY 7, 2022

Arthrex, Inc., Sotera Wireless, Inc. In Sotera Wireless, Inc. Reynolds Vapor Company v. The most active petitioners in 2021 were Sarepta Therapeutics, Inc., The most active patent owners in 2021 were Ravgen, Inc., Regeneron Pharmaceuticals, Inc., and Celltrion, Inc. See United States v.

Reporting 52

Reporting Art Invention Patent 52